Conditions: Migraine
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 346
Healthy volunteers: no

Brief summary:
Study to test the effectiveness of a marketed drug in the treatment of migraine-associated nausea.

Detailed description:

Arms:
arm 1: Rizatriptan (MK0462)10 mg orally disintegrating tablet/oral lyophilisate arm 2: matching placebo

Interventions: intervention 1: Comparator: Rizatriptan intervention 2: Comparator: Placebo
Intervention descriptions: intervention 1: One dose Rizatriptan 10 mg orally disintegrating tablet / oral lyophilisate to treat one migraine attack. intervention 2: One dose matching placebo to Rizatriptan to treat one migraine attack.

Protocol document: